Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted rapidly in vivo to SPR719, the ...

Investing.com -- Pfizer Inc. (NYSE: PFE) stock fell 1.5% following reports that U.S. prosecutors are investigating a claim ...

In a business where drug development needs many shots on goal to be successful, Pfizer has the financial resources and established research power to support the development of innovative new drugs.

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S.